These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12459464)

  • 81. Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.
    Iyer S; Acharya KR
    FEBS J; 2011 Nov; 278(22):4304-22. PubMed ID: 21917115
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cord blood administration induces oligodendrocyte survival through alterations in gene expression.
    Rowe DD; Leonardo CC; Hall AA; Shahaduzzaman MD; Collier LA; Willing AE; Pennypacker KR
    Brain Res; 2010 Dec; 1366():172-88. PubMed ID: 20883670
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vascular endothelial growth factors and vascular permeability.
    Bates DO
    Cardiovasc Res; 2010 Jul; 87(2):262-71. PubMed ID: 20400620
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.
    Kim WY; Lee HY
    FEBS J; 2009 Sep; 276(17):4653-64. PubMed ID: 19664069
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage.
    Di Lorenzo A; Fernández-Hernando C; Cirino G; Sessa WC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14552-7. PubMed ID: 19622728
    [TBL] [Abstract][Full Text] [Related]  

  • 86. ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.
    Martinelli R; Gegg M; Longbottom R; Adamson P; Turowski P; Greenwood J
    Mol Biol Cell; 2009 Feb; 20(3):995-1005. PubMed ID: 19073885
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.
    García C; Aranda J; Arnold E; Thébault S; Macotela Y; López-Casillas F; Mendoza V; Quiroz-Mercado H; Hernández-Montiel HL; Lin SH; de la Escalera GM; Clapp C
    J Clin Invest; 2008 Jun; 118(6):2291-300. PubMed ID: 18497878
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Using guinea pigs in studies relevant to asthma and COPD.
    Canning BJ; Chou Y
    Pulm Pharmacol Ther; 2008 Oct; 21(5):702-20. PubMed ID: 18462968
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
    Moasser MM; Wilmes LJ; Wong CH; Aliu S; Li KL; Wang D; Hom YK; Hann B; Hylton NM
    J Magn Reson Imaging; 2007 Dec; 26(6):1618-25. PubMed ID: 17968965
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling.
    Ma G; Al-Shabrawey M; Johnson JA; Datar R; Tawfik HE; Guo D; Caldwell RB; Caldwell RW
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):415-27. PubMed ID: 16955284
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.
    Phung TL; Ziv K; Dabydeen D; Eyiah-Mensah G; Riveros M; Perruzzi C; Sun J; Monahan-Earley RA; Shiojima I; Nagy JA; Lin MI; Walsh K; Dvorak AM; Briscoe DM; Neeman M; Sessa WC; Dvorak HF; Benjamin LE
    Cancer Cell; 2006 Aug; 10(2):159-70. PubMed ID: 16904613
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.
    Ackah E; Yu J; Zoellner S; Iwakiri Y; Skurk C; Shibata R; Ouchi N; Easton RM; Galasso G; Birnbaum MJ; Walsh K; Sessa WC
    J Clin Invest; 2005 Aug; 115(8):2119-27. PubMed ID: 16075056
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nitric oxide signaling during myocardial angiogenesis.
    Kondo T; Kobayashi K; Murohara T
    Mol Cell Biochem; 2004 Sep; 264(1-2):25-34. PubMed ID: 15544032
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
    Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
    Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
    [TBL] [Abstract][Full Text] [Related]  

  • 95. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
    Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
    Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.
    Dvorak HF
    J Clin Oncol; 2002 Nov; 20(21):4368-80. PubMed ID: 12409337
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Akt signaling mediates VEGF/VPF vascular permeability in vivo.
    Six I; Kureishi Y; Luo Z; Walsh K
    FEBS Lett; 2002 Dec; 532(1-2):67-9. PubMed ID: 12459464
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.